Skip to content
Aspivix logo
  • News
  • About us
  • Contact
  • English
Search
Close
  • For Healthcare Professionals
  • For Women
  • Resources
Stay Informed
  • News
  • About us
  • Contact
  • English
Stay Informed
  • For Healthcare Professionals
  • For Women
  • Resources
Aspivix logo

Home > ASPIVIX in Migros Magazin: Gynécologie, entre archaïsme et modernité

Untitled-design-13

ASPIVIX in Migros Magazin: Gynécologie, entre archaïsme et modernité

October 30, 2020

Share this story:

Share on Facebook
Share on Linkedin
Share on Twitter

More from our blog

Contraception Journal linkedin (3)

ASPIVIX Announces That Contraception, an International Reproductive Health Journal, Has Published First-In-Women Results Using Novel Cervical Stabilizer In IUD Procedures

Read More
Aspivix-FDA-510k-FDA-Approved

Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer

Read More
Femtech World Blog Cover

Aspivix mentioned in Femtech World about Serie A

Read More
Closed Series A+ funding round

ASPIVIX – Manufacturer of non-traumatic medical devices for gynecology – closes $5M Series A+ Funding Round and receives a large EUREKA-EUROSTARS grant co-funded by Innosuisse, the Swiss Innovation Agency.

Read More
Female clinician shaking hand of young happy Hispanic patient sitting on couch in medical office after ultrasound examination

10 Simple Steps Gynecologists Can Take to Enhance Patient Experience

Read More
Woman stressed about contraceptive myths

5 Common Myths About Contraceptives

Read More
aspivix_MG_0208

A modern approach to women’s healthcare

Read More
aspivix_MG_0243

Clinical data show significantly lower IUD procedural pain and bleeding rates with Aspivix’s novel suction-based cervical device

Read More
News

Aspivix mentioned in Swissquote article about FemTech

Read More
News (1)

Reshaping gynecology with women’s experience in mind

Read More

Company

Home
Product
Resources
Careers
Blog

Contact

Global Headquarters
Aspivix SA
Route de la Corniche 8
1066 Epalinges
Switzerland

Privacy Policy

Terms and Conditions

Disclaimer: Carevix™ device received 510(k) clearance from U.S. FDA. Not cleared or approved for sale in any other market.

© 2023 Aspivix SA. All rights reserved. Aspivix™, and Carevix™ are trademarks or registered trademarks of Aspivix SA and/or its subsidiaries.